Results 121 to 130 of about 1,946,344 (262)

Ebola the Enemy: How the U.S. Media Militarized the 2014 Ebola Epidemic [PDF]

, 2017
The 2014 Ebola outbreak shocked the world. In western Africa, the scale of the tragedy was surprising. But equally surprising was the excessively fearful response of the international public to a disease that most public health experts agreed was ...
Chamness, Sarah
core   +2 more sources

Beyond Privacy Calculus: Understanding Digital Contact Tracing Acceptance Through Surveillance Drift and Agency Theory

Canadian Journal of Administrative Sciences / Revue Canadienne des Sciences de l'Administration, Volume 43, Issue 2, June 2026.
ABSTRACT Digital contact tracing (DCT) has emerged as a promising tool for controlling infectious disease outbreaks, yet its adoption has been hampered by widespread privacy concerns. Prior research studies mainly rely on privacy calculus theory. We extend this view by integrating agency theory to explain how delegating sensitive data to government ...
Félix Joly, Camille Grange, Renaud Legoux   +2 more
wiley   +1 more source

Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus.

PLoS Pathogens, 2008
The phosphoinositide-3 kinase (PI3K) pathway regulates diverse cellular activities related to cell growth, migration, survival, and vesicular trafficking. It is known that Ebola virus requires endocytosis to establish an infection.
Mohammad F Saeed, Andrey A Kolokoltsov, Alexander N Freiberg, Michael R Holbrook, Robert A Davey   +4 more
doaj   +1 more source

Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis [PDF]

, 2017
Ebola virus (EBOV) is an enveloped negative-sense RNA virus that causes sporadic outbreaks with high case fatality rates. Ebola viral protein 30 (eVP30) plays a critical role in EBOV transcription initiation at the nucleoprotein (eNP) gene, with ...
Amarasinghe, Gaya K, Basler, Christopher F, Batra, Jyoti, Leung, Daisy W, Luthra, Priya, Wu, Chao, Xu, Wei   +6 more
core   +2 more sources

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1650-1661, June 2026.
AGILE (NCT04746183) is a Phase Ib/IIa platform, evaluating candidates to treat COVID‐19. Candidate Specific Trial 6 evaluated the safety and optimal dose of a novel intravenous formulation of favipiravir in a dose‐escalating, open‐label, randomized, controlled, Bayesian adaptive Phase Ib trial.
Tim Rowland, Richard FitzGerald, Elizabeth Challenger, Laura Dickinson, Laura J. Else, Lauren Walker, Colin Hale, Victoria Shaw, Callum Kelly, Rebecca Lyon, Jennifer Gibney, Karim Dhamani, Margaret Irwin, Yvanne Enever, Michelle Tetlow, William Wood, Helen Reynolds, Justin Chiong, Orod Osanlou, Henry Pertinez, Katie Bullock, William Greenhalf, Andrew Owen, David G. Lalloo, Michael Jacobs, Julian A. Hiscox, Thomas Jaki, Pavel Mozgunov, Geoffrey Saunders, Gareth Griffiths, Saye H. Khoo, Thomas E. Fletcher, on behalf of the AGILE CST‐6 Study Group, Shazaad Ahmad, Christopher J. Edwards, Lesley Dry, Georgie McKenzie, Aleksandra Ros, Michael Stackpoole, Laura Bradley, Karen Jennings‐Wilding, Nicholas Paton, Fred Hayden, Janet Darbyshire, Amy Lucas, Ulrika Lorch, Andrew Freedman, Richard Knight, Steven Julious   +48 more
wiley   +1 more source

Ebola Virus Persistence in Semen Ex Vivo

Emerging Infectious Diseases, 2016
On March 20, 2015, a case of Ebola virus disease was identified in Liberia that most likely was transmitted through sexual contact. We assessed the efficiency of detecting Ebola virus in semen samples by molecular diagnostics and the stability of Ebola ...
Robert J. Fischer, Seth D. Judson, Kerri Miazgowicz, Trent Bushmaker, Vincent J. Munster   +4 more
doaj   +1 more source

Children's Ebola Recovery Assessment: Sierra Leone [PDF]

, 2015
Nearly half the population of Sierra Leone is under the age of 18 years, and the impact of the Ebola crisis on their lives now and on their future opportunities has been far-reaching: no school; loss of family members and friends to the virus; and ...
Isabelle Risso-Gill, Leah Finnegan
core  

Tenacious Researchers Identify a Weakness in All Ebolaviruses. [PDF]

, 2018
The Ebolavirus genus has at least five members, four of which are known to cause deadly disease in humans. An ideal therapy or a vaccine would protect against all ebolaviruses, but identifying a common weakness in all of them has remained elusive.
DuBois, Rebecca M
core   +1 more source

Infectious Disease Response in Tanzania: Enhanced Strategies From the 2023 to 2025 Marburg Outbreaks

Public Health Challenges, Volume 5, Issue 2, June 2026.
ABSTRACT The 2023 Marburg virus disease (MVD) outbreak in Tanzania, which resulted in nine confirmed cases and six deaths (case fatality rate [CFR]: 66.7%), served as a critical stress test of the national health system, revealing significant gaps in outbreak preparedness across surveillance, laboratory capacity, and infection prevention and control ...
Huda Haque, Faraan O. Rahim, Sameer Abbasi, Nam Nguyen, Erick Mahatara, Alison Jang, Ntuli A. Kapologwe   +6 more
wiley   +1 more source

Ebola Virus Antibodies in Fruit Bats, Bangladesh

Emerging Infectious Diseases, 2013
To determine geographic range for Ebola virus, we tested 276 bats in Bangladesh. Five (3.5%) bats were positive for antibodies against Ebola Zaire and Reston viruses; no virus was detected by PCR.
Kevin J. Olival, Ariful Islam, Meng Yu, Simon J. Anthony, Jonathan H. Epstein, Shahneaz Ali Khan, Salah Uddin Khan, Gary Crameri, Lin-Fa Wang, W. Ian Lipkin, Stephen P. Luby, Peter Daszak   +11 more
doaj   +1 more source